Surgical Advances in Hepatocellular Carcinoma: Optimizing Patients for Resection and Transplant

Description

This liver cancer SIG program addresses the rapidly evolving surgical treatment options for HCC including resection and liver transplantation, which are making more patients with intermediate or even advanced stage disease potentially eligible for curative therapy. This session highlights the changing landscape of surgical options for HCC including identification and optimization of potential candidates for resection or transplant; advances in surgical techniques;  the risk-benefit ratio of liver transplantation; and access to liver transplantation.

Journey Maps

Presentations

8:00 AM - 8:15 AM
Nov 16 2024
San Diego, CA

Downstaging With Liver-Directed and Systemic Therapies

Laura M Kulik, MD, Presenter
Liver Cancer
8:15 AM - 8:30 AM
Nov 16 2024
San Diego, CA

Optimizing for Resection: Pushing the Envelope on Resectability

Christopher Sonnenday, MD, MHS, Panelist
Liver Cancer
8:30 AM - 8:45 AM
Nov 16 2024
San Diego, CA

Novel Surgical Approaches for Hepatocellular Carcinoma

Parissa Tabrizian, MD, FACS, Presenter
Liver Cancer
8:45 AM - 9:00 AM
Nov 16 2024
San Diego, CA

Liver Transplantation for Hepatocellular Carcinoma: Who Benefits Most?

Neil Mehta, MD, Presenter
Liver Cancer
9:00 AM - 9:15 AM
Nov 16 2024
San Diego, CA

Making the Liver Allocation System Work for Patients With Hepatocellular Carcinoma

Julie Heimbach, MD, FAASLD, Presenter
Liver Cancer
9:15 AM - 9:30 AM
Nov 16 2024
San Diego, CA

Panel Discussion

Allison Kwong, MD, Panelist
Liver Cancer

Objectives

  • Identify evolving approaches to patient selection and new surgical techniques for resection of HCC.
  • Recognize the risks and benefits of resection versus transplant for HCC.
  • Identify opportunities to improve the liver allocation system and access to liver transplantation for patients with HCC.
Chair

Andrew M Moon, MD, MPH

University of North Carolina